Skip Nav Destination
Issues
October 2016
-
Cover Image
Cover Image
Targeted cancer treatment. In this issue, Gopal et al, review the molecular mechanisms of vascular complications of targeted cancer therapies. See pp. 1763–1779 for further details.
ISSN 0143-5221
EISSN 1470-8736
In this Issue
Review Articles
Molecular mechanisms for vascular complications of targeted cancer therapies
Clin Sci (Lond) (2016) 130 (20): 1763–1779.
N-glycans of growth factor receptors: their role in receptor function and disease implications
Clin Sci (Lond) (2016) 130 (20): 1781–1792.
Cerebrovascular complications of diabetes: focus on cognitive dysfunction
Clin Sci (Lond) (2016) 130 (20): 1807–1822.
Original Papers
NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling
Elisa Vivoli; Andrea Cappon; Stefano Milani; Benedetta Piombanti; Angela Provenzano; Erica Novo; Alessio Masi; Nadia Navari; Roberto Narducci; Guido Mannaioni; Gloriano Moneti; Claudia P. Oliveira; Maurizio Parola; Fabio Marra
Clin Sci (Lond) (2016) 130 (20): 1793–1806.
Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries
Daniel Morales-Cano; Laura Moreno; Bianca Barreira; Ana M. Briones; Rachele Pandolfi; Javier Moral-Sanz; Maria Callejo; Gema Mondejar-Parreño; Julio Cortijo; Mercedes Salaices; Juan Duarte; Francisco Perez-Vizcaino; Angel Cogolludo
Clin Sci (Lond) (2016) 130 (20): 1823–1836.
Commentaries
Vascular smooth muscle cell dysfunction in diabetes: nuclear receptors channel to relaxation
Clin Sci (Lond) (2016) 130 (20): 1837–1839.
Retractions
Retraction: Regulation of resistin by cyclic mechanical stretch in cultured rat vascular smooth muscle cells
Clin Sci (Lond) (2016) 130 (20): 1841.
Retraction: Resistin contributes to neointimal formation via oxidative stress after vascular injury
Clin Sci (Lond) (2016) 130 (20): 1842.